RMD News and Press, ResMed Inc. From 12/11/23

2023-12-11 16:28:13 ET More on ResMed ResMed: Down 60% With Tremendous Long-Term Potential ResMed: Weight-Loss Drug Worries Provide Buying Opportunity ResMed Inc. (RMD) Q1 2024 Earnings Call Transcript ResMed issues urgent safety notice over magnetic CPAP mas...

SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) announced that it has secured a significant victory after the United States Patent Trial and Appeals Board (PTAB) invalidated the claims New York University (NYU) asserted against ResMed, based on seven NYU patents. I...

2023-12-10 08:22:39 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...

Published in the Journal of the American Medical Association Network Open, study estimates global COPD burden from 2020 through 2050 Study projects disproportionate growth in COPD among women and low-middle income regions SAN DIEGO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- ResMed (NY...

2023-11-28 16:37:00 ET More on Philips Philips Q3 Earnings: Getting More Attractive (Rating Upgrade) Koninklijke Philips N.V (PHG) Q3 2023 Earnings Call Transcript Koninklijke Philips N.V. 2023 Q3 - Results - Earnings Call Presentation Philips Non-GAAP EPS of...

2023-11-24 12:40:05 ET More on ResMed ResMed: Down 60% With Tremendous Long-Term Potential ResMed: Weight-Loss Drug Worries Provide Buying Opportunity ResMed Inc. (RMD) Q1 2024 Earnings Call Transcript ResMed president & COO Rob Douglas to retire amid sev...

2023-11-19 12:00:00 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Perfectly Priced Healthcare Giant Novo Nordisk A/S (NVO) Novo Nordisk R&D Investor Event (Transcript) Eli Lilly: Favorable Developments Continue Regarding Anti-Obesity Drug Franchise ...

2023-11-17 06:49:52 ET More on market strategy S&P 500: Forget The Year-End Rally The Message From 12 Post-CPI Charts SPY: 3 Reasons Not To Believe In This Rally UBS calls for slower growth and rate cuts in 2024 Goldman Sachs channels Taylor Swift...

2023-11-16 23:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-12 05:47:32 ET Summary A list of high-quality dividend growth stocks is identified based on proximity to 52-week lows. Pfizer, Bristol-Myers Squibb, ResMed, and NextEra Energy appear attractively valued based on Future and Historical fair valuations. Pfizer appears to ...